Copyright
©The Author(s) 2026.
World J Transplant. Mar 18, 2026; 16(1): 114233
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114233
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114233
Table 1 Summary of kidney allograft outcomes in combined solid organ transplantation based on major published studies
| Type of combined transplant | Delayed graft function | Acute rejection | Kidney graft failure/survival | Patient survival |
| SLK | (1) 39% of cases (Lunsford et al[11]); (2) Higher with high MELD, vasopressor use, or poor hemodynamic status; and (3) Delayed kidney implantation (up to 48 hours) reduces DGF | Possible lower rejection rates vs KTA thought to be due to an immunomodulatory mechanism conferred by liver | (1) Renal allograft futility in 20.7% (death or dialysis by 3 months, Lunsford et al[11]); and (2) Early graft loss linked to hemodynamic instability and high MELD | Early mortality higher in high-MELD SLK recipients, but long-term survival similar to KTA once stabilized |
| SHKT | (1) 27%-37% of cases (Swanson et al[1], Grupper et al[16]); (2) Linked to pre-transplant mechanical circulatory support and RV pressure elevation; and (3) Delayed kidney implantation (up to 69 hours) can reduce risk | No significant difference vs KTA | 5-year-graft survival 72% (vs 73% in KTA, Choudhury et al[9]) | 5-year patient survival lower (75% vs 84%) due to cardiac comorbidities (Choudhury et al[9]) |
| SLKT | (1) Higher DGF risk than kidney-after-lung (3 vs 0 cases; Mesnard et al[31]); and (2) Often due to circulatory shock during lung transplant | Insufficient data on rejection rates | (1) > 3 times high hazard of kidney graft loss (HR = 3.27, P < 0.001, Chen et al[4]); and (2) Primarily from death with functioning graft | Overall survival lower than KTA due to lung-related mortality, not renal factors |
| SPK | (1) Lower DGF incidence vs KTA (Israni et al[41]); and (2) Improved ischemia times metabolic milieu from normoglycemia | No significant difference vs KTA | Superior long term graft year survival. 10-year survival 78% (vs 60%-65% for KTA, Reddy et al[36], Esmeijer et al[37]) | Improved patient survival and reduced cardiovascular mortality (3.3% vs 19%, Lange et al[39]) |
- Citation: Belal AA, Bourricaudy RA, Saba Z, Alquadan KF, Kazory A, Santos Jr AH. Kidney allograft outcomes in combined kidney with other solid organ transplantation. World J Transplant 2026; 16(1): 114233
- URL: https://www.wjgnet.com/2220-3230/full/v16/i1/114233.htm
- DOI: https://dx.doi.org/10.5500/wjt.v16.i1.114233
